Supreme Court rejects abortion pill challenge
Access to mifepristone has been preserved, though some think it is only a temporary victory


What happened
The Supreme Court on Thursday rejected a push by anti-abortion groups to restrict access to the abortion medication mifepristone, ruling unanimously that plaintiffs lacked standing to bring the case.
Who said what
The anti-abortion doctors named as plaintiffs have "sincere legal, moral, ideological and policy objections" to the widely available drug, Justice Brett Kavanaugh wrote in the ruling, but their "desire to make a drug less available for others does not establish standing to sue." Thursday's ruling was the "first major abortion issue to come before the court since its 2022 decision overturning Roe v. Wade," The Wall Street Journal said. Rejecting the mifepristone challenge on procedural grounds allowed the justices to find "common ground."
Thursday's ruling is "not a 'win' for abortion," Nancy Northup at the Center for Reproductive Rights said in a statement. It simply "maintains the status quo, which is a dire public health crisis in which 14 states have criminalized abortion." This was a "sad day for all who value women's health and unborn children's lives," Katie Daniel at Susan B. Anthony Pro-Life America said to the BBC. But "the fight to stop dangerous mail-order abortion drugs is not over."
What next?
Kavanaugh's ruling held "potentially useful hints for abortion opponents, laying out a path" for similar challenges in the future, Politico said. Anti-abortion leaders anticipate better luck advancing the merits of their case in "litigation Idaho, Kansas and Missouri are pursuing before the same Trump-appointed judge" whose 2023 ruling "would have banned abortion pills nationwide."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Rafi Schwartz has worked as a politics writer at The Week since 2022, where he covers elections, Congress and the White House. He was previously a contributing writer with Mic focusing largely on politics, a senior writer with Splinter News, a staff writer for Fusion's news lab, and the managing editor of Heeb Magazine, a Jewish life and culture publication. Rafi's work has appeared in Rolling Stone, GOOD and The Forward, among others.
-
September 13 editorial cartoons
Cartoons Saturday's political cartoons include court-approved racial profiling and America's moral compass
-
Giorgio Armani obituary: designer revolutionised the business of fashion
In the Spotlight ‘King Giorgio’ came from humble beginnings to become a titan of the fashion industry and redefine 20th century clothing
-
Crossword: September 13, 2025
The Week's daily crossword puzzle
-
Nadine Menendez gets 4.5 years in bribery case
Speed Read Menendez's husband was previously sentenced to 11 years in prison
-
Koreans detained in US Hyundai raid return home
Speed Read Over 300 Koreans were detained at the plant last week
-
Brazil’s Bolsonaro sentenced to 27 years for coup attempt
Speed Read Bolsonaro was convicted of attempting to stay in power following his 2022 election loss
-
Former top FBI agents sue, claiming Trump purge
Speed Read The agents alleged they were targeted by a “campaign of retribution”
-
Conservative influencer Charlie Kirk shot dead at 31
Speed Read Kirk was holding a debate session at Utah Valley University
-
Judge lets Cook stay at Fed while appealing ouster
Speed Read Trump had attempted to fire Cook over allegations of mortgage fraud
-
Why are federal judges criticizing SCOTUS?
Today's Big Question Supreme Court issues Trump case rulings 'with little explanation'
-
Can Trump put his tariffs on stronger legal footing?
Today's Big Question Appeals court says 'emergency' tariffs are improper